Yahoo Web Search

Search results

1. • 

     Viking Therapeutics (VKTX) Shares Rose in Q1

     Insider Monkey via Yahoo Finance· 9 hours ago

     Fred Alger Management, an investment management company, released its “Alger Small Cap Growth Fund” first quarter 2024 investor letter. A copy of the...

2. • Too Much Sitting Could Be Harming Kids' Livers

     US News & World Report· 3 days ago

     Kids who spend more than six hours a day on their duffs have a greater risk of severe fatty liver disease and liver cirrhosis by the time they’re young adults, a new study claims. Children have ...

3. • Zealand Pharma Shares Jump After Drug Shows Promise in Liver Trial

     Market Watch· 1 day ago

     Zealand Pharma shares rose after a drug candidate being tested as a treatment for obesity showed positive results in a mid-stage clinical trial for a type of fatty liver disease. At 1544 GMT ...

4. • 

     LIFESAVING TRANSPLANT: Yard sale fundraiser set for Saturday to benefit 6-year-old in need of liver...

     Idaho State Journal· 4 days ago

     A grandmother’s love extends across the miles, and Dianne Norton is hoping hers stretches all the...

5. • 

     Hunter Biden's ex-wife and former girlfriend testify at trial about finding his drug paraphernalia

     Roanoke Times· 2 days ago

     Hunter Biden's ex-wife and a former girlfriend testified Wednesday in his gun trial about finding...

6. • 

     Findings from studies presented at Digestive Disease Week

     Medical Xpress· 3 days ago

     Digestive Disease Week, the annual meeting sponsored by the American Association for the Study of...

7. • 

     Increasing Evidence Suggests Ozempic (Semaglutide) Helps Curb Alcoholism

     Forbes· 2 days ago

     A recent study found obese patients who take the obesity and weight loss drug semaglutide have a...

8. • Researchers use spatial multi-omics to investigate liver zonation and role of GPR35 in disease...

     Medical Xpress· 4 days ago

     Metabolic dysfunction-associated steatotic liver disease (MASLD), an escalating metabolic disorder, poses a severe challenge to global health. However, our understanding of its underlying molecular mechanisms remains limited.

9. • 

     Vir Biotechnology (VIR) Up on Positive Data From HDV Study

     Zacks via Yahoo Finance· 23 hours ago

     Vir Biotechnology (VIR) rises on upbeat data from its phase II study evaluating tobevibart and...

10. • 

      Bulevirtide/Pegylated Interferon Combo Beats Monotherapy for Chronic Hepatitis D

      MedPage Today· 1 day ago

      At 24 weeks after the end of treatment, HDV RNA levels were undetectable in 46% of patients who...